Co-lead says rapamycin can be repurposed to slow ovaries from ageing and is safe for younger women
Why sex bias in labs means women are the losers in research into ageing
A drug that could extend women’s fertility by five years – and help them live longer in better health – is safe for a young, healthy population, according to early results of a study.
The research into repurposing the immunosuppressant rapamycin has been hailed a “paradigm shift” in how menopause is studied.
